
Silence Therapeutics plc SLN
€ 5.08
-1.43%
Geschäftsbericht 2023
hinzugefügt 27.12.2025
Silence Therapeutics plc P/B 2011-2026 | SLN
P/B Jährlich Silence Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 69.8 | - | - | - | - | 0.639 | - | - | - | - |
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 69.8 | 0.639 | 35.2 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 91.21 | 0.03 % | $ 27.2 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
51.7 | $ 330.79 | 3.74 % | $ 43.3 B | ||
|
BioLineRx Ltd.
BLRX
|
19.9 | $ 2.34 | 5.72 % | $ 908 M | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
Cerus Corporation
CERS
|
7.63 | $ 1.87 | 0.27 % | $ 356 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
2.09 | $ 0.46 | -13.08 % | $ 5.27 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
CNS Pharmaceuticals
CNSP
|
0.234 | $ 2.29 | 1.11 % | $ 1.02 M | ||
|
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
3.07 | $ 2.97 | -0.67 % | $ 253 M | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Catalyst Pharmaceuticals
CPRX
|
3.19 | $ 24.91 | 0.89 % | $ 3.05 B | ||
|
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
0.862 | $ 10.08 | -0.88 % | $ 134 M | ||
|
Cardiff Oncology
CRDF
|
2.56 | $ 1.59 | 0.32 % | $ 106 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | ||
|
Curis
CRIS
|
1.74 | $ 0.53 | -3.58 % | $ 6.98 M | ||
|
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.1 | -0.85 % | $ 438 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
4.14 | $ 37.76 | 1.42 % | $ 3.55 B | ||
|
CRISPR Therapeutics AG
CRSP
|
2.28 | $ 49.35 | -0.32 % | $ 4.44 B | ||
|
CytomX Therapeutics
CTMX
|
9.4 | $ 4.35 | -4.61 % | $ 600 M | ||
|
Citius Pharmaceuticals
CTXR
|
0.327 | $ 0.88 | 2.44 % | $ 5.92 M | ||
|
Cue Biopharma
CUE
|
1.11 | $ 0.17 | -6.06 % | $ 16.1 M | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
1.01 | $ 8.24 | 2.55 % | $ 226 M | ||
|
Cyclerion Therapeutics
CYCN
|
0.684 | $ 4.13 | -32.85 % | $ 10.4 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
Daré Bioscience
DARE
|
5.94 | $ 1.77 | 1.75 % | $ 19.8 M | ||
|
DBV Technologies S.A.
DBVT
|
16.7 | $ 20.47 | -2.8 % | $ 2.86 B | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
3.87 | $ 31.46 | 1.29 % | $ 2.09 B | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M |